Chmielowska , E. “Liposomal Doxorubicin in First Line Metastatic HER-2-Positive Breast Cancer for Prevention the Cardiotoxicity”. OncoReview, Vol. 5, no. 1(17), Mar. 2015, pp. 11-15, doi:10.5604/20828691.1147502.